0
Industry
Geography
Report Type
Price
Publication date
Published Date
  • Product Insights

    $100 | November 2023
    Product Insights

    Buire-le-sec – Innovent

    Buire-le-sec - Innovent is an Onshore Wind project located in Hauts-de-France, France. The project is owned and developed by InnoVent. The project came online in 2017. Empower your strategies with our Buire-le-sec - Innovent report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or...

  • Product Insights

    New
    $2,000 | June 2024
    Product Insights
    New

    Tuberous Sclerosis – Drugs In Development, 2024

    Empower your strategies with our Tuberous Sclerosis – Drugs In Development, 2024 report and make more profitable business decisions. Tuberous sclerosis complex (TSC), an autosomal dominant genetic disorder, impacts multiple systems with an elevated tendency for hamartoma formation. Mutations in TSC1 and TSC2 genes, governing proteins that regulate cell division and growth, underlie the disorder. Typically identified in childhood or infancy, TSC manifests with developmental delays, skin issues, and seizures. Diagnosis relies on clinical criteria, supplemented by genetic testing, which detects...

  • Product Insights

    New
    $2,000 | June 2024
    Product Insights
    New

    Male Sexual Dysfunction – Drugs In Development, 2024

    Empower your strategies with our Male Sexual Dysfunction – Drugs In Development, 2024 report and make more profitable business decisions. Male sexual dysfunction encompasses a range of difficulties that can affect a man's ability to engage in sexual activity or experience satisfaction from sexual activity. It can manifest in various forms and can be caused by physical, psychological, or relational factors. Erectile dysfunction (ED) is one of the most common, characterized by the inability to achieve or maintain an erection firm...

  • Product Insights

    New
    $2,000 | June 2024
    Product Insights
    New

    Encephalitis – Drugs In Development, 2024

    Empower your strategies with our Encephalitis – Drugs In Development, 2024 report and make more profitable business decisions. Encephalitis is an inflammation of the brain tissue. There are two main types of encephalitis: primary and secondary. Primary encephalitis occurs when a virus directly infects the brain and spinal cord. Secondary encephalitis occurs when an infection starts elsewhere in the body and then travels to brain. Causes include common viruses, childhood viruses, and arboviruses. Risk factors include age and weak immune system....

  • Product Insights

    New
    $2,000 | June 2024
    Product Insights
    New

    Hypersecretory Conditions – Drugs In Development, 2024

    Empower your strategies with our Hypersecretory Conditions – Drugs In Development, 2024 report and make more profitable business decisions. Hypersecretory Condition is a group of disorders characterized by hypersecretion of gastric acid also known as hypergastrinemia. This condition can result in peptic ulcers, GERD, gastrointestinal hemorrhage causing a predominant mortality and morbidity. Underlying diseases, helicobacter pylori infection, gastric outlet obstruction, chronic renal failure and idiopathic causes results to hypersecretion of gastric juice. Diagnosed by the gastrin levels and gastric acid secretion...

  • Product Insights

    New
    $2,000 | June 2024
    Product Insights
    New

    Insulin Resistance – Drugs In Development, 2024

    Empower your strategies with our Insulin Resistance – Drugs In Development, 2024 report and make more profitable business decisions. Insulin resistance (IR) is a condition in which the body's cells become resistant to the effects of insulin. This occurs when insulin levels are sufficiently high over a prolonged period of time, causing the body’s own sensitivity to the hormone to be reduced. Symptoms include lethargy, hunger, difficulty concentrating, and high blood pressure. Predisposing factors include obesity and hypertension. The Insulin Resistance...

  • Product Insights

    New
    $2,000 | June 2024
    Product Insights
    New

    Methylmalonic Acidemia – Drugs In Development, 2024

    Empower your strategies with our Methylmalonic Acidemia – Drugs In Development, 2024 report and make more profitable business decisions. Methylmalonic Acidemia is an inborn or inherited metabolic disease where the levels of MMA (methylmalonic acid) are elevated in blood and urine. Deficiency in MMA Defect in conversion of methylmalonyl-coenzyme A (CoA) to succinyl-CoA causes accumulation of methylmalonyl-CoA and other potentially toxic compounds. It can be mild to severe appearing in early stages of life or in later stages. Seizures, encephalopathy and...

  • Product Insights

    New
    $2,000 | June 2024
    Product Insights
    New

    Myocarditis – Drugs In Development, 2024

    Empower your strategies with our Myocarditis – Drugs In Development, 2024 report and make more profitable business decisions. Myocarditis is inflammation of the heart muscle. Myocarditis is an uncommon disorder that is usually caused by viral, bacterial, or fungal infections that reach the heart. Symptoms include chest pain; rapid or abnormal heartbeat; shortness of breath, at rest or during physical activity; fluid retention with swelling of the legs, ankles, and feet; and fatigue. Treatment includes antibiotics, anti-inflammatory medicines to reduce swelling;...

  • Product Insights

    New
    $2,000 | June 2024
    Product Insights
    New

    Osteonecrosis – Drugs In Development, 2024

    Empower your strategies with our Osteonecrosis – Drugs In Development, 2024 report and make more profitable business decisions. Osteonecrosis is bone death caused by poor blood supply to the area. It is most common in the hip and shoulder, but can affect other large joints such as knee, elbow, wrist, and ankle. Osteonecrosis can be caused by disease or a severe trauma, such as a break or dislocation, that affects the blood supply to the bone. There are no symptoms in...

  • Product Insights

    New
    $2,000 | June 2024
    Product Insights
    New

    Pouchitis – Drugs In Development, 2024

    Empower your strategies with our Pouchitis – Drugs In Development, 2024 report and make more profitable business decisions. Pouchitis is an inflammatory condition that occurs as a complication in patients who underwent restorative proctocolectomy or also defined as a condition resulting after the pouch surgery. Genetic mutations may also result in this condition. Increased stool frequency, strong urge for bowel movement, abdominal pain, and presented with fever, dehydration, malnutrition. There is no specific treatment for pouchitis generally off-label drugs used for...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.